NEW YORK (GenomeWeb) – Trovagene said today it has closed a public offering of its common stock that brought in $23 million in gross proceeds. 

The company sold 5,111,110 shares of its shares, including 666,666 shares that were issued when the offering's underwriters exercised their overallotment option in full. The offering price was $4.50 per share, Trovagene said. The firm plans to use net proceeds for R&D, working capital, and other general corporate purposes. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.